MICAFUNGIN PHARMAZAC 50 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

micafungin pharmazac 50 mg

rompharm company s.r.l. - romania - micafunginum - pulb. pt. conc. pt. sol. perf. - 50mg - antimicotice de uz sistemic alte antimicotice sistemice

Aubagio Uniunea Europeană - română - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomidă - scleroză multiplă - imunosupresoare selective - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

SITAGLIPTIN/CLORHIDRAT DE METFORMIN PHARMAZAC 50 mg/1000 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sitagliptin/clorhidrat de metformin pharmazac 50 mg/1000 mg

remedica ltd. - cipru - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale

SITAGLIPTIN/CLORHIDRAT DE METFORMIN PHARMAZAC 50 mg/850 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sitagliptin/clorhidrat de metformin pharmazac 50 mg/850 mg

remedica ltd. - cipru - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale

Teriflunomide Mylan Uniunea Europeană - română - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomidă - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Uniunea Europeană - română - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomidă - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare, imunosupresoare selective - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

SANDOSTATIN LAR 10 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sandostatin lar 10 mg

novartis pharma gmbh - germania - octreotidum - pulb. si solv. pt. susp. inj. - 10mg - hormoni hipotalamici hormoni anticrestere

SANDOSTATIN LAR 20 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sandostatin lar 20 mg

novartis pharma gmbh - germania - octreotidum - pulb. si solv. pt. susp. inj. - 20mg - hormoni hipotalamici hormoni anticrestere

SANDOSTATIN LAR 30 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sandostatin lar 30 mg

novartis pharma gmbh - germania - octreotidum - pulb. si solv. pt. susp. inj. - 30mg - hormoni hipotalamici hormoni anticrestere

Ionsys Uniunea Europeană - română - EMA (European Medicines Agency)

ionsys

incline therapeutics europe ltd - fentanil clorhidrat - durere, postoperator - analgezice - ionsys este indicat pentru tratamentul durerii postoperatorii moderate până la severe la pacienții adulți.